Redesign Science

Redesign Science, founded in 2017, is a bio-computation and innovative drug discovery company. The company’s mission is to apply cutting-edge protein dynamic simulation technology for precise structure prediction, pushing the boundaries of drug development. Redesign Science boasts the world's top molecular dynamics-based new drug research and development team.The Redesign Science computational platform leverages advanced technologies such as long-timescale molecular dynamics simulations, statistical physics, and machine learning to facilitate the drug discovery process for novel targets, hard-to-drug targets, and other protein targets with limited data. Using this platform, the company has successfully identified hit compounds across multiple fields, including precision oncology treatments and inflammatory bowel disease.